Limited clinical benefit of minority K103N-and Y181C-variant quantification in addition to routine genotypic resistance testing in ART-naive patientsK. J. Metzner,A. U. Scherrer,V. von Wyl, C. Leemann,J. Boeni,S. Yerly,T. Klimkait,V. Aubert,H. Furrer,M. Battegay,P. L. Vernazza,M. Cavassini,A. Calmy,E. Bernasconi, R. Weber,H. F. GuenthardANTIVIRAL THERAPY(2013)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要